Published in N Engl J Med on February 23, 1995
Heritability of cardiovascular and personality traits in 6,148 Sardinians. PLoS Genet (2006) 8.19
The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med (2000) 5.72
Clinical pharmacokinetics of atorvastatin. Clin Pharmacokinet (2003) 2.18
Low HDL cholesterol is a risk factor for deficit and decline in memory in midlife: the Whitehall II study. Arterioscler Thromb Vasc Biol (2008) 1.88
The physician and pharmacist team. An effective approach to cholesterol reduction. J Gen Intern Med (1997) 1.84
Endothelial function in the time of the giants. J Cardiovasc Pharmacol (2008) 1.41
An in vitro study of the probiotic potential of a bile-salt-hydrolyzing Lactobacillus fermentum strain, and determination of its cholesterol-lowering properties. Appl Environ Microbiol (2003) 1.15
HMG-CoA reductase inhibitors inhibit endothelial exocytosis and decrease myocardial infarct size. Circ Res (2005) 1.14
A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid. Br J Pharmacol (2001) 1.13
L-2-Oxothiazolidine-4-carboxylic acid reverses endothelial dysfunction in patients with coronary artery disease. J Clin Invest (1998) 1.05
Use of cholesterol-lowering therapy and related beliefs among middle-aged adults after myocardial infarction. J Gen Intern Med (2002) 0.98
Rosuvastatin enhances angiogenesis via eNOS-dependent mobilization of endothelial progenitor cells. PLoS One (2013) 0.90
Microencapsulated Genetically Engineered Lactobacillus plantarum 80 (pCBH1) for Bile Acid Deconjugation and Its Implication in Lowering Cholesterol. J Biomed Biotechnol (2004) 0.90
Effects of flavonoid-containing beverages and EGCG on endothelial function. J Am Coll Nutr (2007) 0.89
Endothelin-1, aging and hypertension. Curr Opin Cardiol (2008) 0.88
Comparison of the effects of 52 weeks weight loss with either a high-protein or high-carbohydrate diet on body composition and cardiometabolic risk factors in overweight and obese males. Nutr Diabetes (2012) 0.87
Yoga training improves metabolic parameters in obese boys. Korean J Physiol Pharmacol (2012) 0.87
Short-term exercise training prevents micro- and macrovascular disease following coronary stenting. J Appl Physiol (1985) (2010) 0.84
Statins exert the pleiotropic effects through small GTP-binding protein dissociation stimulator upregulation with a resultant Rac1 degradation. Arterioscler Thromb Vasc Biol (2013) 0.83
Hypolipidemic effect ofAlpinia galanga (Rasna) andKaempferia galanga (Kachoori). Indian J Clin Biochem (1997) 0.83
The new paradigm of public health nutrition. Am J Public Health (1995) 0.81
The Effect of Cilostazol on Endothelial Function as Assessed by Flow-Mediated Dilation in Patients with Coronary Artery Disease. J Atheroscler Thromb (2016) 0.81
Diabetes-specific nutrition algorithm: a transcultural program to optimize diabetes and prediabetes care. Curr Diab Rep (2012) 0.80
How do calcium channel blockers prevent cardiovascular events. Are they all alike? Drugs (1996) 0.78
Long-term administration of rosuvastatin prevents contractile and electrical remodelling of diabetic rat heart. J Bioenerg Biomembr (2013) 0.78
Lack of a relationship between plasma PCSK9 concentrations and hepatic lipoprotein kinetics in obese people. Transl Res (2011) 0.78
Fenofibrate Reduces Age-related Hypercholesterolemia in Normal Rats on a Standard Diet. Korean J Physiol Pharmacol (2010) 0.78
Alterations of coronary blood flow and myocardial perfusion in hypercholesterolaemia. Heart (1996) 0.78
Single frequency intake of α-linolenic acid rich phytosterol esters attenuates atherosclerosis risk factors in hamsters fed a high fat diet. Lipids Health Dis (2016) 0.77
Influence of soy lecithin administration on hypercholesterolemia. Cholesterol (2009) 0.77
Achieving lipid goals with rosuvastatin compared with simvastatin in high risk patients in real clinical practice: a randomized, open-label, parallel-group, multi-center study: the DISCOVERY-Beta study. Vasc Health Risk Manag (2008) 0.76
Atherosclerosis and physical activity. Oman Med J (2009) 0.76
Intensive Statin Therapy in NSTE-ACS Patients Undergoing PCI: Clinical and Biochemical Effects. Tex Heart Inst J (2015) 0.76
Statin effect on thrombin inhibitor effectiveness during percutaneous coronary intervention: a post-hoc analysis from the ISAR-REACT 3 trial. Clin Res Cardiol (2011) 0.76
The role of the kidney and the sympathetic nervous system in hypertension. Pediatr Nephrol (2014) 0.75
Klotho Contributes to Pravastatin Effect on Suppressing IL-6 Production in Endothelial Cells. Mediators Inflamm (2016) 0.75
Association of body mass index and abdominal adiposity with atherogenic lipid profile in Nigerians with type 2 diabetes and/or hypertension. Niger Med J (2013) 0.75
Edible bird's nest attenuates procoagulation effects of high-fat diet in rats. Drug Des Devel Ther (2015) 0.75
Vascular function and Endothelin-1: Tipping the Balance between Vasodilation and Vasoconstriction. J Appl Physiol (1985) (2016) 0.75
In Vivo Antihypercholesterolemic Potential of Swietenia mahagoni Leaf Extract. Cholesterol (2016) 0.75
Hemodynamic effects of peri-operative statin therapy in on-pump cardiac surgery patients. J Cardiothorac Surg (2012) 0.75
Thiazolidinedione-independent activation of peroxisome proliferator-activated receptor γ is a potential target for diabetic macrovascular complications. J Diabetes Investig (2012) 0.75
Evaluation of Mallotus oppositifolius Methanol Leaf Extract on the Glycaemia and Lipid Peroxidation in Alloxan-Induced Diabetic Rats: A Preliminary Study. Biochem Res Int (2013) 0.75
A six-month, multicenter, open-label, noncomparative, prospective, observational study of the efficacy and tolerability of atorvastatin in the primary care setting(estudio del control de las hiperlipidemiasen atención primaria): the cheap study. Curr Ther Res Clin Exp (2003) 0.75
Dyslipidemia in rat fed with high-fat diet is not associated with PCSK9-LDL-receptor pathway but ageing. J Geriatr Cardiol (2013) 0.75
Thin-film microfabricated nanofluidic arrays for size-selective protein fractionation. Lab Chip (2013) 0.75
Monascus purpureus-fermented Thai glutinous rice reduces blood and hepatic cholesterol and hepatic steatosis concentrations in diet-induced hypercholesterolemic rats. BMC Complement Altern Med (2015) 0.75
Anti-diabetic activities of the methanol leaf extracts of Hymenocardia acida (tul.) in alloxan-induced diabetic rats. Afr J Tradit Complement Altern Med (2011) 0.75
Amlamax in the management of dyslipidemia in humans. Indian J Pharm Sci (2010) 0.75
Alteration of glucose lowering effect of glibenclamide on single and multiple treatments with fenofibrate in experimental rats and rabbit models. J Basic Clin Pharm (2014) 0.75
Endothelial Dysfunction is Associated with Occult Coronary Artery Disease Detected by Positron Emission Tomography. IJC Metab Endocr (2014) 0.75
Simvastatin attenuates renal ischemia/reperfusion injury from oxidative stress via targeting Nrf2/HO-1 pathway. Exp Ther Med (2017) 0.75
Treatment of hypertension with ascorbic acid. Lancet (1999) 4.74
Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study. Aging Cell (2006) 3.44
Antioxidants and atherosclerotic heart disease. N Engl J Med (1997) 2.86
The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. N Engl J Med (1991) 2.74
Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation (1996) 2.28
A noninvasive method of predicting pulmonary-capillary wedge pressure. N Engl J Med (1992) 2.12
Inflammatory biomarkers are associated with total brain volume: the Framingham Heart Study. Neurology (2007) 2.05
Clinical clues to the cause of Addison's disease. Am J Med (1985) 1.91
Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation (2001) 1.89
Iron chelation improves endothelial function in patients with coronary artery disease. Circulation (2001) 1.88
Acute hypertriglyceridemia is associated with peripheral vasodilation and increased basal flow in healthy young adults. Am J Cardiol (2001) 1.85
Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem (1997) 1.77
Psychosocial factors impair vascular responses of coronary arteries. Circulation (1991) 1.64
Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ Res (1998) 1.58
In vivo transfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols. J Clin Invest (1994) 1.53
Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin. J Biol Chem (2000) 1.52
Atherosclerosis impairs flow-mediated dilation of coronary arteries in humans. Circulation (1989) 1.52
c-Jun N-terminal kinase activation by hydrogen peroxide in endothelial cells involves SRC-dependent epidermal growth factor receptor transactivation. J Biol Chem (2001) 1.49
NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties. J Clin Invest (1993) 1.44
Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation (1990) 1.42
Nitroglycerin is preferable to diltiazem for prevention of coronary bypass conduit spasm. Ann Thorac Surg (2000) 1.41
Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation (1993) 1.40
Effects of race and hypertension on flow-mediated and nitroglycerin-mediated dilation of the brachial artery. Hypertension (2001) 1.38
Beneficial effects of angiotensin-converting enzyme inhibitors during acute revascularization. Ann Thorac Surg (1998) 1.38
Are ACE inhibitors a "magic bullet" against oxidative stress? Circulation (2001) 1.36
Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation (1999) 1.34
Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide. J Clin Invest (1995) 1.32
New insights on oxidative stress in the artery wall. J Thromb Haemost (2005) 1.29
Antiplatelet properties of protein S-nitrosothiols derived from nitric oxide and endothelium-derived relaxing factor. Arterioscler Thromb (1993) 1.28
Nitric oxide released from activated platelets inhibits platelet recruitment. J Clin Invest (1997) 1.28
alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. Circulation (1996) 1.24
Role of nitric oxide in parasympathetic modulation of beta-adrenergic myocardial contractility in normal dogs. J Clin Invest (1995) 1.22
Dietary antioxidants preserve endothelium-dependent vessel relaxation in cholesterol-fed rabbits. Proc Natl Acad Sci U S A (1993) 1.16
Nitrosation of tryptophan residue(s) in serum albumin and model dipeptides. Biochemical characterization and bioactivity. J Biol Chem (1996) 1.07
Impaired platelet production of nitric oxide predicts presence of acute coronary syndromes. Circulation (1998) 1.07
Low-dose alpha-tocopherol improves and high-dose alpha-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits. J Clin Invest (1994) 1.06
Ischemia, hyperemia, exercise, and nitric oxide. Complex physiology and complex molecular adaptations. Circulation (1994) 1.06
L-2-Oxothiazolidine-4-carboxylic acid reverses endothelial dysfunction in patients with coronary artery disease. J Clin Invest (1998) 1.05
Atherosclerosis, oxidative stress, and antioxidant protection in endothelium-derived relaxing factor action. Prog Cardiovasc Dis (1995) 1.04
Pharmacological concentrations of ascorbic acid are required for the beneficial effect on endothelial vasomotor function in hypertension. Hypertension (2000) 1.04
Enhanced nitric oxide-mediated vascular relaxation in radial artery compared with internal mammary artery or saphenous vein. Circulation (1999) 1.04
17 beta-estradiol preserves endothelial vasodilator function and limits low-density lipoprotein oxidation in hypercholesterolemic swine. Circulation (1994) 1.02
Effect of ascorbic acid treatment on conduit vessel endothelial dysfunction in patients with hypertension. Am J Physiol Heart Circ Physiol (2001) 1.02
Epicardial coronary artery responses to acetylcholine are impaired in hypertensive patients. Circ Res (1992) 1.01
Homocysteine-induced nitric oxide production in vascular smooth-muscle cells by NF-kappa B-dependent transcriptional activation of Nos2. Proc Assoc Am Physicians (1998) 0.98
Increased plasma levels of lipid hydroperoxides in patients with ischemic stroke. Free Radic Biol Med (1998) 0.96
Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation. J Clin Invest (1995) 0.96
Non-invasive assessment of brachial artery endothelial vasomotor function: the effect of cuff position on level of discomfort and vasomotor responses. Vasc Med (1998) 0.95
Antioxidants and the bioactivity of endothelium-derived nitric oxide. Cardiovasc Res (2000) 0.94
Vascular superoxide dismutase deficiency impairs endothelial vasodilator function through direct inactivation of nitric oxide and increased lipid peroxidation. Arterioscler Thromb Vasc Biol (1997) 0.94
Contrasting effects of thiol-modulating agents on endothelial NO bioactivity. Am J Physiol Cell Physiol (2001) 0.94
Stimulation of endothelial nitric oxide production by homocyst(e)ine. Atherosclerosis (1997) 0.94
Clinical and genetic correlates of soluble P-selectin in the community. J Thromb Haemost (2007) 0.93
Vascular incorporation of alpha-tocopherol prevents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation. J Clin Invest (1996) 0.93
Effect of acute and chronic tea consumption on platelet aggregation in patients with coronary artery disease. Arterioscler Thromb Vasc Biol (2001) 0.91
Coronary artery perforation during excimer laser coronary angioplasty. The percutaneous Excimer Laser Coronary Angioplasty Registry. J Am Coll Cardiol (1993) 0.89
Diurnal rhythms and clinical events in coronary artery disease. Postgrad Med J (1991) 0.89
Association between arterial stiffness and variations in oestrogen-related genes. J Hum Hypertens (2009) 0.88
Antioxidant protection of LDL by physiological concentrations of 17 beta-estradiol. Requirement for estradiol modification. Circulation (1997) 0.87
Redox control of vascular nitric oxide bioavailability. Antioxid Redox Signal (2000) 0.86
Vitamin E inhibition of platelet aggregation is independent of antioxidant activity. J Nutr (2001) 0.85
Effect of vitamin E on aortic lipid oxidation and intimal proliferation after arterial injury in cholesterol-fed rabbits. Free Radic Biol Med (2001) 0.84
Hormone replacement therapy and endothelial function: the exception that proves the rule? Arterioscler Thromb Vasc Biol (2001) 0.84
Acute effects of a high-fat meal with and without red wine on endothelial function in healthy subjects. Am J Cardiol (1999) 0.83
Reflex increase in blood pressure during the intracoronary administration of adenosine in man. J Clin Invest (1989) 0.82
Exercise--toning up the endothelium? N Engl J Med (2000) 0.81
Antioxidants and cardiovascular disease; panaceas or tonics for tired sheep? Cardiovasc Res (2000) 0.81
Ascorbic acid and glutathione modulate the biological activity of S-nitrosoglutathione. Hypertension (2000) 0.81
Loss of the coronary microvascular response to acetylcholine in cardiac transplant patients. Circulation (1992) 0.81
Diabetes, oxidative stress, and platelet activation. Circulation (1999) 0.81
Determination of phospholipid oxidation in cultured cells. Methods Enzymol (1999) 0.80
High-dose heparin decreases nitric oxide production by cultured bovine endothelial cells. Circulation (1997) 0.80